These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30968417)

  • 61. Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Matthews AM; Fireman M; Zucker B; Sobel M; Hauser P
    Am J Psychiatry; 2006 Aug; 163(8):1342-7; quiz 1479. PubMed ID: 16877644
    [No Abstract]   [Full Text] [Related]  

  • 62. Micro-elimination of HCV as a possible therapeutic strategy: our experience and a review of literature.
    Bojovic K; Simonovic-Babic J; Mijailovic Z; Milosevic I; Jovanovic M; Ruzic M; Cvejic Pasic T; Svorcan P; Petrovic M; Jordovic J
    J Infect Dev Ctries; 2020 Feb; 14(2):117-124. PubMed ID: 32146444
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.
    Echevarria D; Gutfraind A; Boodram B; Major M; Del Valle S; Cotler SJ; Dahari H
    PLoS One; 2015; 10(8):e0135901. PubMed ID: 26295805
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
    Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
    World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
    Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
    Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths.
    Sievert W; Razavi H; Thompson A; Zekry A; Dore GJ; Roberts SK
    Med J Aust; 2015 May; 202(9):479. PubMed ID: 25971570
    [No Abstract]   [Full Text] [Related]  

  • 68. Hepatitis C viral infection among prisoners.
    Kostić V; Radović J; Djordjević J; Vujić S
    Vojnosanit Pregl; 2013 Nov; 70(11):1006-9. PubMed ID: 24397194
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epidemiology of hepatitis C virus infection in Australia.
    Dore GJ; MacDonald M; Law MG; Kaldor JM
    Aust Fam Physician; 2003 Oct; 32(10):796-8. PubMed ID: 14596073
    [No Abstract]   [Full Text] [Related]  

  • 70. Why is there still hepatitis C transmission in Australian prisons? A case report.
    Harkness B; Levy M; Evans R; Wenke J
    Harm Reduct J; 2017 Nov; 14(1):75. PubMed ID: 29178927
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
    Zanini B; Lanzini A
    Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Obstacles to successful HCV treatment in substance addicted patients.
    Cooper CL
    J Addict Dis; 2008; 27(2):61-8. PubMed ID: 18681192
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
    Reekie JM; Levy MH; Richards AH; Wake CJ; Siddall DA; Beasley HM; Kumar S; Butler TG
    Med J Aust; 2014 Mar; 200(5):277-80. PubMed ID: 24641153
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Are we nearing the end in the fight against hepatitis C?
    Chua JV; Kottilil S
    Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):499-500. PubMed ID: 28335650
    [No Abstract]   [Full Text] [Related]  

  • 75. Responding to hepatitis C through the criminal justice system.
    Rich JD; Allen SA; Williams BA
    N Engl J Med; 2014 May; 370(20):1871-4. PubMed ID: 24827032
    [No Abstract]   [Full Text] [Related]  

  • 76. Treatment of hepatitis C: momentum still needed.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):289. PubMed ID: 29644967
    [No Abstract]   [Full Text] [Related]  

  • 77. [Elimination of hepatitis C is possible].
    Midgard H; Kielland KB; Dalgard O
    Tidsskr Nor Laegeforen; 2018 Apr; 138(7):. PubMed ID: 29663789
    [No Abstract]   [Full Text] [Related]  

  • 78. Editorial: Towards the eradication of hepatitis C virus.
    Marcellin P; Asselah T
    Liver Int; 2012 Feb; 32 Suppl 1():1. PubMed ID: 22212564
    [No Abstract]   [Full Text] [Related]  

  • 79. Localized US Efforts to Eliminate Hepatitis C.
    Gaudino A; Gay B; Garmon C; Selick M; Vreeland R; Burk K; Huriaux E; Facente SN; Luetkemeyer A; Waters P; Graham CS
    Infect Dis Clin North Am; 2018 Jun; 32(2):293-311. PubMed ID: 29778257
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The success of treatment of chronic hepatitis C in opiate addicts in Clinical Center of Vojvodina.
    Odavić M; Preveden T
    Med Pregl; 2014; 67(3-4):123-9. PubMed ID: 24961056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.